Is sjögren’s disease the overlooked CTD associated with an hypersensitivity pneumonitis pattern?
Borie R, Nocturne G, Crestani B, Seror R
Am J Respir Crit Care Med
FHU Infire Publications
Publications
Find all scientific publications from FHU INFIRE.
2026
Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 “DICIPLE” Phase III Trial
Zalcman G, Madroszyk A, Guenzi E, Dayen C, Molinier O, Egenod T, Poté N, Debieuvre D, Beaucaire-Danel S, Dixmier A, Pichon E, Galland-Girodet S, Giroux-Leprieur E, Cloarec N, Cadranel J, Otto J, Romand P, Favier L, Martinez S, Mascaux C, Odier L, Cortot A, Audigier-Valette C, Langlais A, Amour E, Morin F, Antoine M, Gounant V, Westeel V, Toffart AC
J Thorac Oncol
2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Scherpereel A, Baas P, Nowak AK, Tsao AS, Fujimoto N, Peters S, Mansfield AS, Popat S, Bautista Aragon Y, Talbot T, Grossi F, Kowalski D, Kaplan MA, Cardona AF, Soomro R, Hu N, Lee A, Ip V, Hung YH, Zalcman G
J Clin Oncol
2026
Urate Lowering and Cardiovascular Risk-Extending the Benefits of a Treat-to-Target Strategy in Gout
Richette P, Latourte A, Ea HK
JAMA Intern Med
2026
Mucin O-glycosylation and B-cell homing: a new bridge for the gut-kidney axis in IgA nephropathy?
Gleeson PJ, Cogné M, Monteiro RC
Kidney Int
2026
Pulmonary hypertension associated with hereditary haemorrhagic telangiectasia: from genetics to clinical management
Jutant EM, Grynblat J, Pyrrait M, Lechartier B, Olitsky S, Ghigna MR, Dupuis-Girod S, Coulet F, Savale L, Humbert M, Ataya A, Montani D
Eur Respir J
2026
Long-Term Clinical and Hemodynamic Outcomes of Transcatheter Mitral Valve Replacement
Groshenry N, Suc G, Mesnier J, Delhomme C, Cailliau A, Brochet E, Ducrocq G, Farnoud R, Bleuze L, Himbert D, Haviari S, Iung B, Urena M
JACC Cardiovasc Interv
2026
Severe allergic transfusion reactions to B/AB plasma or platelets in group O recipients are linked to α‑Gal sensitization
de Chaisemartin L, de la Taille V, Nicaise-Roland P, Malard L, Beuscart C, Gouel-Cheron A, Laperche S, Tiberghien P
Blood